[["NKX2.1 mutations", "have been identified in", "patients displaying complete or partial brain-lung-thyroid syndrome"], ["brain-lung-thyroid syndrome", "can include", "benign hereditary chorea (BHC), hypothyroidism and/or lung disease"], ["Multiplex Ligation-dependent Probe Amplification (MLPA) method", "was evaluated to assess", "the relative copy number of genes"], ["MLPA", "was used to determine if", "it could improve the detection rate of NKX2.1 mutations"], ["Direct sequencing", "revealed", "two heterozygous mutations"], ["MLPA", "identified", "two further heterozygous NKX2.1 gene deletions"], ["MLPA", "increased", "the detection rate by 50%"], ["All patients with gene deletions", "were affected by", "BHC and congenital hypothyroidism"], ["MLPA", "should be considered as", "a complementary tool in patients with partial or total brain-lung-thyroid syndrome"], ["All patients with an NKX2.1 mutation", "had", "BHC and congenital hypothyroidism"], ["NKX2.1 mutations", "emphasize", "the high prevalence of BHC and congenital hypothyroidism associated with defective NKX2.1 alleles"]]